HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction.

AbstractBACKGROUND AND OBJECTIVES:
Some recent data indicate that risk of death after acute coronary syndrome is under genetic control. Previously, we found that the C4B*Q0 genotype (low copy number of the C4B gene that encodes the fourth component of complement) is strongly associated with morbidity and mortality of cardiovascular diseases (CVD). The +252 G allele of the lymphotoxin-alpha (LTA) gene encoded close to the C4B gene was also reported to be related to CVD-related mortality in an Oriental population.
METHODS:
The relationship between the copy number of the genes encoding the fourth component of complement (C4A and C4B) and LTA 252 single-nucleotide polymorphism (SNP) on the one hand and mortality after acute myocardial infarction (AMI) was studied in 142 Icelandic patients. The number of the C4A and C4B genes was determined in genomic DNA samples by a newly developed real-time PCR-based method; lymphotoxin-alpha (LTA) +252 A>G polymorphism was determined by PCR-restriction fragment length polymorphism analysis.
RESULTS:
The C4B*Q0 genotype was found to be strongly associated with 1-year mortality, with a hazard ratio of 3.50 (1.38-8.87) (P = 0.008) (adjusted Cox regression analysis). This association was, however, restricted to ever-smoking patients. By contrast, neither C4A gene copy numbers nor LTA 252 SNP did confer increased risk of mortality after AMI.
CONCLUSIONS:
This observation indicates that low C4B copy number is a strong risk factor for short-term mortality after AMI in smoking Icelandic patients, whereas LTA 252 G allele is not a risk factor in Caucasian population.
AuthorsBernadett Blaskó, Ragnhildur Kolka, Perla Thorbjornsdottir, Sigurdur Thór Sigurdarson, Gardar Sigurdsson, Zsolt Rónai, Mária Sasvári-Székely, Sigurdur Bödvarsson, Gudmundur Thorgeirsson, Zoltán Prohászka, Margit Kovács, George Füst, Gudmundur Jóhann Arason
JournalInternational immunology (Int Immunol) Vol. 20 Issue 1 Pg. 31-7 (Jan 2008) ISSN: 1460-2377 [Electronic] England
PMID18032375 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Lymphotoxin-alpha
  • Complement C4b
Topics
  • Aged
  • Aged, 80 and over
  • Complement C4b (genetics)
  • Female
  • Gene Dosage
  • Genetic Predisposition to Disease
  • Humans
  • Iceland
  • Lymphotoxin-alpha (genetics)
  • Male
  • Myocardial Infarction (genetics, mortality)
  • Polymerase Chain Reaction (methods)
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Smoking (adverse effects)
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: